The following adjustment was made today on Novartis (NVS). All prices include IB commissions.
| Criteria | Value |
|---|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 10 |
| Fair Value Estimate | $69.00* |
| Target Buy Price | $55.20 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $55.00 |
| Actual Margin of Safety | 20.29% |
*Fair Value was lowered from $71 to $69 since inception with no impact on my original Margin of Safety.
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 7/27/2012 | NVS | Continued Trade | STO 1 Sep12 60.00 Call @ 0.54 | $54.25 |
Current Position Summary
| Cost Basis | ($5,250.00) |
| Income Generated | $222.94 |
| Percent Income Generated | 4.25% |
| Annualized Income Generated | 6.46% |
| Net Profit If Assigned | $972.94 |
| Percent Return If Assigned | 18.53% |
| Annualized Return If Assigned | 28.18% |
| Days Held to Expiration | 240 days |
Trade History
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|---|---|---|---|---|---|
| 1/25/2012 | NVS | CSP Margin Used | CSP 100 NVS @ 52.50 | ($5,250.00) | ||
| 1/25/2012 | NVS | Initial Put Option | STO 1 Mar12 52.50 Put @ 1.18 | Expired | $117.97 | |
| 3/22/2012 | NVS | Continued Trade | STO 1 May12 52.50 Put @ 0.51 | Exercised | $50.72 | |
| 5/18/2012 | NVS | CSP Margin Returned | CSP 100 NVS @ -52.50 | $5,250.00 | ||
| 5/18/2012 | NVS | Stock Assigned | EX 1 May12 52.50 Put @ -52.50 | ($5,250.00) | ||
| 7/27/2012 | NVS | Continued Trade | STO 1 Sep12 60.00 Call @ 0.54 | $54.25 | ||
| 9/21/2012 | NVS | Totals | ($5,250.00) | $222.94 | ||
| DTE | 240 | Percent Income/Annualized | 4.25% | 6.46% |
